Pathobiology and management of laboratory rodents administered CDC Category A agents
- 1 February 2007
- journal article
- review article
- Vol. 57 (1) , 18-32
Abstract
The Centers for Disease Control and Prevention Category A infectious agents include Bacillus anthracis (anthrax), Clostridium botulinum toxin (botulism), Yersinia pestis (plague), variola major virus (smallpox), Francisella tularensis (tularemia), and the filoviruses and arenaviruses that induce viral hemorrhagic fevers. These agents are regarded as having the greatest potential for adverse impact on public health and therefore are a focus of renewed attention in infectious disease research. Frequently rodent models are used to study the pathobiology of these agents. Although much is known regarding naturally occurring infections in humans, less is documented on the sources of exposures and potential risks of infection to researchers and animal care personnel after the administration of these hazardous substances to laboratory animals. Failure to appropriately manage the animals can result both in the creation of workplace hazards if human exposures occur and in disruption of the research if unintended animal exposures occur. Here we review representative Category A agents, with a focus on comparing the biologic effects in naturally infected humans and rodent models and on considerations specific to the management of infected rodent subjects. The information reviewed for each agent has been curated manually and stored in a unique Internet-based database system called HazARD (Hazards in Animal Research Database, http://helab.bioinformatics.med.umich.edu/hazard/) that is designed to assist researchers, administrators, safety officials, institutional Biosafety Committees, and veterinary personnel seeking information on the management of risks associated with animal studies involving hazardous substances.This publication has 38 references indexed in Scilit:
- Tropical dermatology: Bacterial tropical diseasesJournal of the American Academy of Dermatology, 2006
- A Mutant ofFrancisella tularensisStrain SCHU S4 Lacking the Ability To Express a 58-Kilodalton Protein Is Attenuated for Virulence and Is an Effective Live VaccineInfection and Immunity, 2005
- The solute‐binding component of a putative Mn(II) ABC transporter (MntA) is a novel Bacillus anthracis virulence determinantMolecular Microbiology, 2005
- Laboratory-Confirmed Transmission of Vaccinia Virus Infection through Sexual Contact with a Military VaccineeJournal of Clinical Microbiology, 2004
- Tularemia: the disease and the weaponDermatologic Clinics, 2004
- Enhancement of the Endopeptidase Activity of Purified Botulinum Neurotoxins A and E by an Isolated Component of the Native Neurotoxin Associated ProteinsBiochemistry, 2004
- Vaccinia Virus Infection during Murine Pregnancy: a New Pathogenesis Model for Vaccinia FetalisJournal of Virology, 2004
- A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infectionJournal of General Virology, 2003
- Neuronal Nitric Oxide Synthase-ImmunoreactivityORL, 2002
- Exposure of Laboratory Workers to Francisella tularensis despite a Bioterrorism ProcedureJournal of Clinical Microbiology, 2002